文献速递银屑病与炎症性皮肤病

角质形成细胞而非T细胞中的IL-6R/STAT3信号诱导小鼠银屑病样皮炎

IL-6R/Signal Transducer and Activator of Transcription 3 Signaling in Keratinocytes rather than in T Cells Induces Psoriasis-Like Dermatitis in Mice.
PubMed 文献 · J Invest Dermatol · 2021-10-07

该研究在咪喹莫特诱导的小鼠银屑病样皮炎模型中,比较角质形成细胞(KC)与T细胞中STAT3信号的相对贡献。结果显示KC特异性STAT3缺失减轻皮炎和表皮STAT3磷酸化,而T细胞STAT3缺失无此效果;KC中IL-6Rα缺失模拟STAT3缺失表型,且皮炎与1型免疫基因产物CXCL10负相关,提示KC STAT3通过限制CXCL10促进皮炎。托法替尼可减轻皮炎和表皮STAT3磷酸化。

要点

  • KC而非T细胞中的STAT3信号是银屑病样皮炎的关键决定因素
  • KC IL-6Rα是STAT3诱导皮炎的主要上游信号
  • KC STAT3通过抑制CXCL10限制1型免疫反应促进皮炎

核心结论

  • 角质形成细胞而非T细胞中的STAT3信号是咪喹莫特诱导小鼠银屑病样皮炎更重要的决定因素。

研究设计与样本

  • 在咪喹莫特诱导的小鼠银屑病样皮炎模型中,比较KC诱导性STAT3缺失小鼠(K5-Stat3-/-)、全部T细胞组成性STAT3缺失小鼠与野生型小鼠。
  • 进一步评估KC诱导性IL-6Rα缺失小鼠及托法替尼治疗小鼠。

主要发现

  • K5-Stat3-/-小鼠银屑病样皮炎减轻且表皮STAT3磷酸化降低,而T细胞STAT3缺失小鼠与野生型相似。
  • KC诱导性IL-6Rα缺失小鼠表现与K5-Stat3-/-小鼠相似。
  • 银屑病样皮炎与1型免疫基因产物尤其CXCL10呈负相关,CXCL10限制皮炎。
  • 托法替尼减轻小鼠银屑病样皮炎和表皮STAT3磷酸化。

临床怎么用

  • 提示靶向角质形成细胞IL-6R/STAT3轴可能治疗银屑病,托法替尼在此模型中有效。

局限性

  • 研究基于咪喹莫特诱导的小鼠模型,结论外推至人类银屑病需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Signal transducer and activator of transcription 3 (STAT3) is important for psoriasis pathogenesis because STAT3 signaling downstream of IL-6, IL-21, IL-22, and IL-23 contributes to T helper type 17 cell development and because transgenic mice with keratinocyte (KC) STAT3 expression (K14-Stat3C mice) develop psoriasis-like dermatitis. In this study, the relative contribution of STAT3 signaling in KCs versus in T cells was evaluated in the imiquimod model of psoriasis-like dermatitis. Mice with STAT3-inducible deletion in KCs (K5-Stat3-/- mice) had decreased psoriasis-like dermatitis and epidermal STAT3 phosphorylation compared with wild-type mice, whereas mice with constitutive deletion of STAT3 in all T cells were similar to wild-type mice. Interestingly, mice with KC-inducible deletion of IL-6Rα had similar findings to those of K5-Stat3-/- mice, identifying IL-6/IL-6R as a predominant upstream signal for KC STAT3-induced psoriasis-like dermatitis. Moreover, psoriasis-like dermatitis inversely associated with type 1 immune gene products, especially CXCL10, whereas CXCL10 limited psoriasis-like dermatitis, suggesting that KC STAT3 signaling promoted psoriasis-like dermatitis by restricting downstream CXCL10 expression. Finally, treatment of mice with the pan-Jak inhibitor, tofacitinib, reduced psoriasis-like dermatitis and epidermal STAT3 phosphorylation. Taken together, STAT3 signaling in KCs rather than in T cells was a more important determinant for psoriasis-like dermatitis in a mechanism that involved upstream KC IL-6R signaling and downstream inhibition of type 1 immunity‒associated CXCL10 responses.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Ravipati A, Nolan S, Alphonse M, et al. IL-6R/Signal Transducer and Activator of Transcription 3 Signaling in Keratinocytes rather than in T Cells Induces Psoriasis-Like Dermatitis in Mice. J Invest Dermatol. 2021. PMID: 34626614. doi:10.1016/j.jid.2021.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。